Vaxart (VXRT) News Today $0.72 +0.03 (+4.33%) (As of 11/12/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Vaxart (VXRT) to Release Earnings on WednesdayVaxart (NASDAQ:VXRT) will be releasing earnings after the market closes on Wednesday, November 13, Zacks reports.November 8, 2024 | marketbeat.comVaxart to Host Third Quarter 2024 Business Update and Financial Results Conference Call on November 13November 7, 2024 | markets.businessinsider.comComparing Black Diamond Therapeutics (NASDAQ:BDTX) and Vaxart (NASDAQ:VXRT)November 6, 2024 | americanbankingnews.comVaxart (NASDAQ:VXRT) Stock Price Passes Below 200 Day Moving Average - Time to Sell?Vaxart (NASDAQ:VXRT) Shares Pass Below Two Hundred Day Moving Average - Here's What HappenedNovember 1, 2024 | marketbeat.comVaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024October 24, 2024 | markets.businessinsider.comVaxart will present research on COVID-19, norovirus vaccine candidatesOctober 24, 2024 | markets.businessinsider.comVaxart (NASDAQ:VXRT) Share Price Passes Below 200-Day Moving Average - Should You Sell?Vaxart (NASDAQ:VXRT) Stock Crosses Below 200-Day Moving Average - Time to Sell?October 24, 2024 | marketbeat.comVaxart, Inc. (NASDAQ:VXRT) Shares Purchased by Millennium Management LLCMillennium Management LLC grew its stake in shares of Vaxart, Inc. (NASDAQ:VXRT - Free Report) by 110.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,985,670 shares of the biotechnology company's stock after purchasinOctober 16, 2024 | marketbeat.comOppenheimer Sticks to Their Buy Rating for Vaxart (VXRT)October 3, 2024 | markets.businessinsider.comVaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine CandidateSeptember 30, 2024 | globenewswire.comVaxart (NASDAQ:VXRT) Stock Price Crosses Above 200-Day Moving Average of $0.84Vaxart (NASDAQ:VXRT) Shares Pass Above 200 Day Moving Average of $0.84September 26, 2024 | marketbeat.comVaxart (NASDAQ:VXRT) Stock Passes Above 200-Day Moving Average of $0.85Vaxart (NASDAQ:VXRT) Stock Price Crosses Above 200-Day Moving Average of $0.85September 18, 2024 | marketbeat.comMonaco Asset Management SAM Makes New $402,000 Investment in Vaxart, Inc. (NASDAQ:VXRT)Monaco Asset Management SAM purchased a new position in shares of Vaxart, Inc. (NASDAQ:VXRT - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 601,700 shares of the biotechnologySeptember 10, 2024 | marketbeat.comVaxart (NASDAQ:VXRT) Stock Price Crosses Below 200 Day Moving Average of $0.88Vaxart (NASDAQ:VXRT) Shares Pass Below 200-Day Moving Average of $0.88September 3, 2024 | marketbeat.comVaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 30, 2024 | globenewswire.comVaxart's Pre-clinical Data Reveals Potential Of Mucosal Vaccine Platform For HPV- Cervical DysplasiaAugust 29, 2024 | markets.businessinsider.comFY2024 EPS Estimates for Vaxart, Inc. (NASDAQ:VXRT) Lifted by AnalystVaxart, Inc. (NASDAQ:VXRT - Free Report) - Analysts at Cantor Fitzgerald boosted their FY2024 EPS estimates for shares of Vaxart in a research note issued to investors on Thursday, August 22nd. Cantor Fitzgerald analyst C. Duncan now expects that the biotechnology company will post earnings of ($August 26, 2024 | marketbeat.comVaxart’s Promising Vaccine Pipeline: Leading in Mucosal Immunity with Government Support and Competitive AdvantagesAugust 16, 2024 | markets.businessinsider.comVanguard Group Inc. Acquires 1,404,391 Shares of Vaxart, Inc. (NASDAQ:VXRT)Vanguard Group Inc. grew its holdings in Vaxart, Inc. (NASDAQ:VXRT - Free Report) by 19.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,449,362 shares of the biotechnology company's stock after acqAugust 15, 2024 | marketbeat.comVXRT Stock Earnings: Vaxart Misses EPS, Beats Revenue for Q2 2024August 8, 2024 | investorplace.comVaxart Provides Business Update and Reports Second Quarter 2024 Financial ResultsAugust 8, 2024 | globenewswire.comVaxart (VXRT) to Release Quarterly Earnings on ThursdayVaxart (NASDAQ:VXRT) will be releasing earnings after the market closes on Thursday, August 8, Zacks reports.August 3, 2024 | marketbeat.comVaxart to Host Second Quarter 2024 Business Update and Financial Results Conference Call on August 8August 2, 2024 | globenewswire.comVaxart (NASDAQ:VXRT) Stock Price Passes Below Two Hundred Day Moving Average of $0.92Vaxart (NASDAQ:VXRT) Share Price Passes Below 200-Day Moving Average of $0.92July 31, 2024 | marketbeat.comVaxart (NASDAQ:VXRT) Stock Passes Below 200-Day Moving Average of $0.91Vaxart (NASDAQ:VXRT) Stock Crosses Below Two Hundred Day Moving Average of $0.91July 9, 2024 | marketbeat.comVaxart (NASDAQ:VXRT) Stock Passes Below Two Hundred Day Moving Average of $0.90Vaxart (NASDAQ:VXRT) Stock Passes Below Two Hundred Day Moving Average of $0.90June 28, 2024 | marketbeat.comVaxart, Inc. (NASDAQ:VXRT) Director W. Mark Watson Acquires 20,000 SharesJune 21, 2024 | insidertrades.comVaxart Provides Business UpdateJune 17, 2024 | globenewswire.comVaxart Announces $40 Million Underwritten Offering of Common StockJune 13, 2024 | globenewswire.comVaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine CandidateJune 13, 2024 | globenewswire.comVaxart (NASDAQ:VXRT) Shares Cross Below 200-Day Moving Average of $0.91Vaxart (NASDAQ:VXRT) Stock Passes Below Two Hundred Day Moving Average of $0.91June 11, 2024 | marketbeat.comBrokers Offer Predictions for Vaxart, Inc.'s FY2024 Earnings (NASDAQ:VXRT)Vaxart, Inc. (NASDAQ:VXRT - Free Report) - Analysts at Cantor Fitzgerald reduced their FY2024 earnings per share estimates for Vaxart in a report released on Wednesday, May 29th. Cantor Fitzgerald analyst C. Duncan now expects that the biotechnology company will earn ($0.54) per share for the yeaJune 3, 2024 | marketbeat.comVaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 23, 2024 | globenewswire.comVaxart, Inc. (NASDAQ:VXRT) Q1 2024 Earnings Call TranscriptMay 14, 2024 | insidermonkey.comVaxart Inc (VXRT) Q1 2024 Earnings Call Transcript Highlights: Promising Developments and ...May 14, 2024 | finance.yahoo.comVaxart Provides Business Update and Reports First Quarter 2024 Financial ResultsMay 13, 2024 | globenewswire.comVaxart earnings preview: what to expectMay 12, 2024 | markets.businessinsider.comVaxart (VXRT) Scheduled to Post Earnings on MondayVaxart (NASDAQ:VXRT) will be releasing earnings after the market closes on Monday, May 13, Zacks reports.May 8, 2024 | marketbeat.comVaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13May 7, 2024 | finance.yahoo.comVaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating MothersApril 30, 2024 | globenewswire.comElection Year Encore: Can 2020's Top 7 Stock Winners Repeat Their Performance in 2024?April 9, 2024 | investorplace.comVaxart to Present at World Vaccine Congress Washington 2024 on April 3March 27, 2024 | globenewswire.comVaxart, Inc. (NASDAQ:VXRT) Expected to Earn Q1 2024 Earnings of ($0.18) Per ShareVaxart, Inc. (NASDAQ:VXRT - Free Report) - Equities research analysts at B. Riley issued their Q1 2024 earnings estimates for shares of Vaxart in a research note issued on Wednesday, March 20th. B. Riley analyst M. Mamtani expects that the biotechnology company will earn ($0.18) per share for theMarch 22, 2024 | marketbeat.comResearch Analysts Issue Forecasts for Vaxart, Inc.'s Q2 2024 Earnings (NASDAQ:VXRT)Vaxart, Inc. (NASDAQ:VXRT - Free Report) - Investment analysts at B. Riley issued their Q2 2024 earnings per share estimates for Vaxart in a report issued on Wednesday, March 20th. B. Riley analyst M. Mamtani forecasts that the biotechnology company will earn ($0.15) per share for the quarter. B.March 21, 2024 | marketbeat.comVaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 20, 2024 | globenewswire.comEstimating The Intrinsic Value Of Vaxart, Inc. (NASDAQ:VXRT)March 17, 2024 | finance.yahoo.comVaxart, Inc. (NASDAQ:VXRT) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comVXRT Stock Earnings: Vaxart Beats EPS, Beats Revenue for Q4 2023March 14, 2024 | investorplace.comVaxart Inc (VXRT) Reports Full Year 2023 Financial ResultsMarch 14, 2024 | finance.yahoo.comVaxart Provides Business Update and Reports Full Year 2023 Financial ResultsMarch 14, 2024 | globenewswire.com Get Vaxart News Delivered to You Automatically Sign up to receive the latest news and ratings for VXRT and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here VXRT Media Mentions By Week VXRT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VXRT News Sentiment▼0.660.60▲Average Medical News Sentiment VXRT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VXRT Articles This Week▼41▲VXRT Articles Average Week Get Vaxart News Delivered to You Automatically Sign up to receive the latest news and ratings for VXRT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Inovio Pharmaceuticals News Today Aligos Therapeutics News Today SIGA Technologies News Today Aura Biosciences News Today Terns Pharmaceuticals News Today PureTech Health News Today Altimmune News Today Foghorn Therapeutics News Today Arcturus Therapeutics News Today KalVista Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VXRT) was last updated on 11/13/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredYou just voted for a financial crisisI’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the asse...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxart, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxart With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
